A new preclinical study titled "Intravitreal Transplantation of Retinal Progenitor Cells Improves Outcome Measures in a Rat ...
Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, ...
An intravitreal ranibizumab injection was able to improve retinal sensitivity and thickness along with improving visual acuity. Branch retinal vein occlusion (BRVO) can affect people aged 40 years and ...
Patients with age-related macular degeneration may have “transient” adverse macular changes after cataract surgery, but these ...
The MCO-010 vector uses surviving cells in the retina to produce a photosensitive protein that may help patients regain some ...
Scientists have developed a new eyedrop that can ferry protective compounds all the way to the retina, paving the way for a ...
Clearside Biomedical Showcases Suprachoroidal Injection Platform for Retinal Diseases at CTS Meeting
Clearside Biomedical, Inc. has announced that its suprachoroidal injection delivery platform will be prominently featured at the Clinical Trials at the Summit (CTS) Meeting on June 21, 2025, in Las ...
People with macular degeneration had relied on a Manitoba ophthalmologist who travelled periodically to Kenora, Ont., to ...
Seven different postoperative complications occurred two to four times more often in patients who had a history of intravitreal drug injections as compared with those who did not. Among complications ...
MISSISSAUGA, ON, Aug. 29, 2025 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that VABYSMO ® (faricimab injection) is now publicly funded for macular edema secondary to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results